Guidelines Make Hormone Therapy First-Line for Menopause

The American College of Obstetricians and Gynecologists issues new guidance on treating menopause symptoms such as hot flashes and sleep disturbance.

Updated on Nov. 17, 2026 in Women’s Health

Guidelines Make Hormone Therapy First-Line for Menopause

Live Poll

Would you trust your doctor's advice on menopause hormone therapy today?

The American College of Obstetricians and Gynecologists released guidelines on November 17, 2026, recommending hormone therapy as a first-line treatment for many women experiencing menopause symptoms, including hot flashes and related sleep disturbances. The guidance is intended to address misconceptions about hormone replacement therapy risks.

Why it matters

Misconceptions about hormone replacement therapy stemmed in part from a 2002 study that some read as showing increased risk of stroke, heart disease and certain cancers. The new guidelines reflect subsequent research providing a more nuanced understanding of those risks, which may affect how women and clinicians across the United States approach symptom treatment.

The original 2002 study enrolled women averaging 63 years old, an age older than many women who begin hormone therapy, a difference the guidelines' age-based approach addresses. The extraction does not detail the revised risk estimates or how the new recommendations quantify benefits against risks.

The players

American College of Obstetricians and Gynecologists

The American College of Obstetricians and Gynecologists is a professional medical organization representing obstetricians and gynecologists in the United States that issues clinical practice guidance.

Dr. Deborah Kwolek

Dr. Deborah Kwolek is a Menopause Society Certified Practitioner and leader of Mass General Brigham's Sex and Gender Medicine Program, a physician focused on women's midlife health.

The details

The guidelines emphasize that treatment decisions should consider a patient's age, medical history and individual risk factors rather than applying a single blanket approach. Dr. Deborah Kwolek, a Menopause Society Certified Practitioner and leader of Mass General Brigham's Sex and Gender Medicine Program, is among the experts associated with this shift in clinical thinking.

Timeline

  1. 2002: A widely publicized study on hormone therapy risks is published.

  2. November 17, 2026: The American College of Obstetricians and Gynecologists releases new menopause hormone therapy guidelines.

Health Landscape

The 2002 Women's Health Initiative study sharply reduced prescribing of hormone replacement therapy after it linked the treatment to elevated stroke, heart disease and cancer risks. The new American College of Obstetricians and Gynecologists guidance reflects later research that refines those conclusions for women in the United States.

Women considering treatment for hot flashes or sleep disruption can discuss hormone therapy with a clinician, weighing age, medical history and individual risk factors. The guidelines frame the decision as individualized rather than one-size-fits-all.

The takeaway

Hormone therapy decisions for menopause depend on personal factors such as age and medical history, so a conversation with a clinician is the practical starting point. The updated guidance encourages individualized evaluation over blanket assumptions about risk.

Further reading

Explore more on Women's Health for related coverage of menopause care in the United States.

Source note: This article includes information reported by WBUR 90.9 mHz.

Live Poll

Would you trust your doctor's advice on menopause hormone therapy today?